
Overview: $120M Series C and Unicorn Status
Assort Health has raised $120 million in Series C funding. This milestone pushes the company’s total capital raised to $222 million and values it at $1.2 billion — officially reaching unicorn status.
Menlo Ventures led the round. Additional backers include Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital. The fresh capital fuels Assort’s mission to build a comprehensive voice AI agent platform specifically for healthcare.
Why Investors Are Betting Big
Matt Murphy, partner at Menlo Ventures, explained the thesis behind the investment. He noted that healthcare has long suffered from inefficient, outdated processes — and that agentic platforms are finally changing that. Murphy pointed to Assort’s strong ROI, higher provider efficacy, and better patient outcomes as key differentiators. He also highlighted that the company has proven its model in specialty care, which he described as “where the heavy lift really is.”
Murphy added that he expects Assort to reach every corner of U.S. healthcare in the coming years.
What Assort Health’s Voice AI Platform Does
From Scheduling to Full Patient Access
Assort Health launched in November 2023. Since then, it has evolved from a specialty scheduling tool into a full-stack patient access platform. Today, the company builds specialty-specific AI voice agents that automate and streamline workflows across orthopedics, cardiology, immunology, and other specialties.
The platform now handles a wide range of functions:
- Inbound and outbound patient calls
- Appointment scheduling and no-show recovery
- Intake forms and document processing
- Referral management and care gap closure
- Medication refills and lab requests
- Real-time insurance eligibility checks
- Payment collection
- Support in any language
Moreover, the platform writes every interaction detail directly back to the electronic health record (EHR). This eliminates manual data entry and reduces administrative burden on front office staff.
AI Copilot for Complex Cases
Beyond automation, the platform also equips staff with an AI copilot. This tool helps teams manage complex patient access needs in real time, ensuring that no edge case falls through the cracks.
The Synapse AI Model: Proprietary Data Advantage
Built on 190 Million Patient Interactions
One of Assort Health’s clearest competitive advantages is its proprietary dataset. The company has built its AI on:
- 190 million patient interactions
- 62,000 care protocols
- 1.6 million decision pathways
This dataset powers Synapse, Assort’s proprietary AI model. Synapse learns the patterns of specialty workflows across every deployment. It then generates edge cases, tests, and simulations that each workflow must handle before going live.
Speed and Scale
Jon Wang, founder and co-CEO, explained that building the original AI agent took six months. Now, thanks to Synapse, what once required months takes weeks. This acceleration enables faster, higher-quality deployments at scale — even across the most complex specialty workflows.
Wang said: “It has unlocked real scale deployment for this product doing the highest automation rates in the lowest amount of time on the most complex workflows.”
Furthermore, the company’s revenue has grown 20x over 15 months — a sign that the model is working in practice, not just in theory.
Patient Journey Memory: Healthcare That Remembers
From Reactive to Proactive Care
The core vision behind Assort’s second phase is what Wang calls “healthcare that remembers.” Instead of forcing patients to repeat their story at every touchpoint, the platform builds a continuous, intelligent record across every interaction.
Wang described it this way: the goal is to shift from a reactive healthcare system — where patients feel invisible — to one that actually knows them.
How Patient Journey Memory Works
Assort Health’s AI agents connect every touchpoint through a “patient journey memory.” Each interaction builds on the previous one, across channels and across the entire care journey. The system automatically carries forward:
- Language preference
- Visit history
- Communication tone
- Open tasks
- Patient sentiment
This data flows through every subsequent interaction, creating an experience that feels personal and continuous rather than transactional. As a result, providers gain a clearer picture of each patient — without additional documentation work.
Real-World Results: MDCS Dermatology Case Study
A Two-Year Partnership
MDCS Dermatology, a multi-location dermatology group operating across New York and New Jersey, has used Assort Health’s platform for two years. The practice started with inbound AI agents for scheduling and triage, then expanded to outbound agents.
Parinita Amin, M.D., CEO of MDCS Dermatology, said the practice evaluated every AI solution on the market before choosing Assort. Her criteria were strict: quality, quality, quality — and a true platform, not another point solution.
Measurable Outcomes
The results speak clearly. MDCS Dermatology, which operates 9 locations and sees 130,000 to 138,000 patient visits annually, has achieved:
- A 4.9-star rating across 30,000 reviews on multiple platforms
- A 20% increase in appointment bookings
- Continued growth, enabling the practice to add providers
Amin credited Assort’s memory-driven approach as the key differentiator. She said: “Everyone else automates one piece and forgets the rest. Assort remembers every patient across every interaction and connects it all into one conversation.”
Expanding Into Health Systems
Beyond Specialty Practices
Assort Health is now moving beyond specialty practices into larger health system operations. The company works with health systems ranging from community-based organizations to academic medical centers. John Muir Health is among the systems partnering with Assort to support complex ambulatory operations.
Jon Shaker, executive director of the Boston Bone and Joint Institute, emphasized that a mishandled interaction can mean losing a new patient entirely. He said Assort’s track record across hundreds of deployments gave his team confidence from day one.
Platform Performance at Scale
Across its customer base, Assort Health reports that providers can expect:
- A 5% lift in appointment volume
- A 115% increase in labor capacity
- Reduced front office workload without adding headcount
These gains come without requiring practices to hire additional staff — a critical advantage given ongoing workforce shortages in healthcare.
Competitive Landscape in Voice AI
A Crowded but Growing Market
The voice AI startup market is expanding fast. Several well-funded competitors are targeting similar opportunities in healthcare:
- Artera secured $65 million in December for AI-powered patient communications
- EliseAI raised $250 million in Series E funding to tackle administrative tasks
- Hello Patient built generative AI agents for medical practice communications
- Tennr raised $101 million to automate document-heavy referral workflows
- Prosper AI recently secured $30 million to scale administrative AI, backed by Andreessen Horowitz
Despite this competition, Assort Health’s co-CEO Jeffery Liu argues the company holds a defensible position. The key, he says, is data — and Assort has more of it than anyone else. He noted that even Anthropic and OpenAI lack the specialty-specific clinical data Assort has accumulated through real deployments.
Liu previously worked as a software engineer at Facebook and Athelas before co-founding Assort Health. He confirmed the company will invest over $70 million in R&D to execute on its roadmap.
What’s Next for Assort Health
Owning the Front Door of Healthcare
Wang’s strategic thesis is straightforward: owning the front door of healthcare unlocks the entire patient journey. By capturing patient communications data and encoding complex business protocols at the point of first contact, Assort can extend its value across every downstream workflow.
Wang also expects market consolidation. He believes provider groups will stop buying point solutions and instead seek a single partner with the capital and engineering depth to transform operations over the long run. He says Assort has built exactly that.
The Road Ahead
With $222 million raised, a $1.2 billion valuation, and a platform that processes millions of specialty interactions, Assort Health is positioning itself as the operating system for patient access in U.S. healthcare. The company’s next phase — building AI that remembers every patient, across every touchpoint, at scale — could redefine what the front end of healthcare looks like.
